Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Tornier Perform Reversed MonoPost Shoulder Implant: Patient Follow-Up in Real World Care

Official title: Tornier Perform™ Reversed Monopost Study

Run by Stryker Trauma and Extremities · NCT07764614 · Data updated 2026-11-12

This study tests how well the Tornier Perform Reversed MonoPost shoulder implant works in adults with shoulder problems over two years by following patients after surgery at multiple centers.

More Traumatic Arthritis trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorStryker Trauma and Extremities
Industry-sponsored
Locations2 sites (Rancho Mirage, California and 1 other locations)
StatusRecruiting
StartedOctober 22, 2026
Main results expectedDecember 30, 2030
Study endsAugust 30, 2031
Registry record updatedOctober 23, 2026
Trial IDNCT07764614 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 and older who have had or will have a shoulder arthroplasty with the Tornier Perform Reversed MonoPost and have a functional deltoid with a massive, non-repairable rotator cuff tear and related conditions.

Probably not a fit

Patients without a suitable post-surgical anatomy or those not receiving this implant may not experience benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multi-center, prospective, post-market follow-up study designed to monitor safety and effectiveness of the Tornier Perform Reversed MonoPost system in real-world shoulder arthroplasty. It plans to enroll about 150 subjects across up to ten sites over one year and will track imaging findings and clinical outcomes as part of routine care. The primary goal is to achieve a mean improvement of 25 points on the ASES Shoulder Score at two years compared with baseline, across two glenoid cohorts. Secondary goals include documenting postoperative complications and functional outcomes to evaluate device performance in typical clinical settings.

Why it matters

Potential benefit: If successful, the study could confirm real-world pain relief and improved shoulder function with the device.

How similar studies have gone: Prior post-market and observational studies in shoulder arthroplasty have shown variable but informative results for similar reverse shoulder implants in real-world use.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years or older at the time of the informed consent.
* Informed and willing to sign an informed consent form (ICF) approved by Institutional Review Board (IRB) or Ethics Committee (EC).
* Willing and able to comply with the requirements of the study protocol
* Considered a candidate or having received shoulder arthroplasty with the device, having a functional deltoid muscle and with massive and non-repairable rotator cuff tear with pain disabled by:

  * Rheumatoid arthritis
  * Non-inflammatory degenerative joint disease (i.e. osteoarthritis and avascular necrosis)
  * Correction of functional deformity
  * Fracture of the Humeral Head
  * Traumatic arthritis
  * Revision of the devices if sufficient bone stock remains
* Enrollment occurred up to 1 year after date of surgery provided that mandatory data are accessible: including ASES, Constant, and Active ROM.

Exclusion Criteria:

* Contraindications or hypersensitivity to the use of the Tornier Perform™ Reversed MonoPost System or their components (e.g., metal sensitivity).
* Participation in the treatment period of another clinical trial during the clinical investigation.
* Any subject that meets the definition of a Vulnerable Subject per ISO 14155 Section 3.44. Examples include any subject "with lack of or loss of autonomy due to immaturity or through mental disability, persons in nursing homes, children, impoverished

Where it's running

  • Eisenhower Health
    Rancho Mirage, California, United States
    Recruiting
  • Ohio State University
    Columbus, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.